Drug intelligence / Profile preview

zeocin

Development stage
Unknown
Lead developer
InvivoGen
Modality
Small Molecules
Administration
Laboratory (in Vitro Selection); Not Intended For Therapeutic Administration
01

Overview

Zeocin is a broad-spectrum, water-soluble, copper-chelated glycopeptide antibiotic, and a member of the bleomycin/phleomycin family isolated from the bacterium Streptomyces verticillus. It is primarily used in molecular biology for the selection of eukaryotic and prokaryotic cell lines with Zeocin resistance. Zeocin exhibits strong toxicity against bacteria, fungi (including yeast), plants, and mammalian cell lines. Its mechanism of action involves entering the cell where the copper ion is reduced and removed, activating the molecule, which then intercalates into DNA and cleaves it, leading to double-stranded DNA breaks and subsequent cell death. Resistance is conferred by the Sh ble gene product which binds Zeocin, preventing DNA cleavage. Zeocin is not intended for therapeutic or diagnostic use in humans or animals; its main application is laboratory selection in research contexts[1][3][5][6][7].

Brand names
Zeocin
Other names
phleomycin D1phytomycin D1bleomycin D1
02

Targets

DNA

Beyond the preview

Go deeper on zeocin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zeocin.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call